PixarBio Analysis
PixarBio holds a debt-to-equity ratio of 0.326. With a high degree of financial leverage come high-interest payments, which usually reduce PixarBio's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
PixarBio's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. PixarBio's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps PixarBio Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect PixarBio's stakeholders.
For most companies, including PixarBio, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for PixarBio, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, PixarBio's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that PixarBio's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which PixarBio is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of PixarBio to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, PixarBio is said to be less leveraged. If creditors hold a majority of PixarBio's assets, the Company is said to be highly leveraged.
PixarBio is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of PixarBio delisted stock analysis is to determine its intrinsic value, which is an estimate of what PixarBio is worth, separate from its market price. There are two main types of PixarBio's stock analysis: fundamental analysis and technical analysis.
The PixarBio stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PixarBio's ongoing operational relationships across important fundamental and technical indicators.
PixarBio |
PixarBio Stock Analysis Notes
About 75.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.19. PixarBio had not issued any dividends in recent years. PixarBio Corporation, a specialty pharmaceuticalbiotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. Pixarbio Corp is traded on OTC Exchange in the United States. To find out more about PixarBio contact the company at 617-803-8838 or learn more at http://www.pixarbio.com.PixarBio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. PixarBio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding PixarBio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| PixarBio is not yet fully synchronised with the market data | |
| PixarBio has some characteristics of a very speculative penny stock | |
| PixarBio has a very high chance of going through financial distress in the upcoming years | |
| PixarBio currently holds 309.67 K in liabilities with Debt to Equity (D/E) ratio of 0.33, which is about average as compared to similar companies. PixarBio has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about PixarBio's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.95 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PixarBio currently holds about 715.11 K in cash with (4.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 75.0% of PixarBio outstanding shares are owned by corporate insiders |
PixarBio Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 81.PixarBio Debt to Cash Allocation
As PixarBio follows its natural business cycle, the capital allocation decisions will not magically go away. PixarBio's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
PixarBio currently holds 309.67 K in liabilities with Debt to Equity (D/E) ratio of 0.33, which is about average as compared to similar companies. PixarBio has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about PixarBio's use of debt, we should always consider it together with its cash and equity.PixarBio Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PixarBio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PixarBio, which in turn will lower the firm's financial flexibility.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PixarBio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in PixarBio Stock
If you are still planning to invest in PixarBio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PixarBio's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |